ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

4-Methylmorpholine → HCID 178445920、化合物

HRID 464905
印刷

反応式

HRID 464905 の反応式
[CH2:1]([O:8][C:9]([NH:11][C@H:12](C(O)=O)[CH2:13][C:14]1[C:23]2[C:18](=[CH:19][CH:20]=[CH:21][CH:22]=2)[CH:17]=[CH:16][CH:15]=1)=[O:10])C1C=CC=CC=1.ON1C(=O)[CH:36]2[CH:31]([CH:32]3C[CH:35]2[CH:34]=[CH:33]3)C1=O.ClC(Cl)CCCCCN=C=N.Br.Br.[C:53]1([CH2:63][C@@H:64]([C:66]([NH:68][C@H:69]([C:76]([NH:78][C@H:79]([CH2:84][OH:85])[CH2:80][CH:81]([CH3:83])[CH3:82])=[O:77])[CH2:70][C:71]2[N:75]=[CH:74][NH:73][CH:72]=2)=[O:67])[NH2:65])[C:62]2[C:57](=[CH:58][CH:59]=[CH:60][CH:61]=2)[CH:56]=[CH:55][CH:54]=1.CN1CC[O:90][CH2:89]C1>CN(C)C=O.C(Cl)Cl>[CH2:1]([O:8][C:9]([NH:11][C@H:12]([C:89]([N:68]([C:66](=[O:67])[C@H:64]([CH2:63][C:53]1[C:62]2[C:57](=[CH:58][CH:59]=[CH:60][CH:61]=2)[CH:56]=[CH:55][CH:54]=1)[NH2:65])[C@H:69]([C:76]([NH:78][C@H:79]([CH2:84][OH:85])[CH2:80][CH:81]([CH3:82])[CH3:83])=[O:77])[CH2:70][C:71]1[N:75]=[CH:74][NH:73][CH:72]=1)=[O:90])[CH2:13][C:14]1[C:19]2[C:18](=[CH:23][CH:22]=[CH:21][CH:20]=2)[CH:17]=[CH:16][CH:15]=1)=[O:10])[C:31]1[CH:36]=[CH:35][CH:34]=[CH:33][CH:32]=1
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

8

反応物 5

HCID 79724-MethylmorpholineHCID 895293a,4,7,7a-Tetrahydro-2-hydroxy-4,7-methano-1H-isoindole-1,3(2H)-dioneHCID 7020250Z-1-Nal-OHHCID 71510291DichlorohexylcarbodiimideHCID 178419252HCID 178419252、化合物

生成物 1

HCID 178445920HCID 178445920、化合物

試薬・触媒・溶媒 2

HCID 6228Dimethylformamide溶媒HCID 6344Dichloromethane溶媒

反応条件

温度
0 °C

実験手順

70 mg. (0.2 mmole) of N-benzyloxycarbonyl-3-(1-naphthyl)-L-alanine and 40 mg. (0.22 mmole) of N-hydroxy-5-norbornene-2,3-dicarboximide were dissolved in 2 ml. of methylene chloride. The solution was cooled to 0° C., and there were then added 50 mg. (0.24 mmole) of dichlorohexylcarbodiimide; the mixture was stirred at 0° C. for 1 hour. The resulting solution was added to a cooled solution prepared from 5 ml. of a dimethylformamide solution of 123 mg. (0.2 ml.) of 3-(1-naphthyl)-L-alanyl-L-histidyl-L-leucinol dihydrobromide by neutralization with 20 mg. (0.2 mmole) of N-methylmorpholine. The mixture was stirred overnight at room temperature. The dicyclohexylurea precipitated was removed by filtration, and the filtrate was concentrated by evaporation under reduced pressure. To the residue was added a 5% w/v aqueous solution of sodium bicarbonate, and the oily substance thus formed was extracted with ethyl acetate. The organic layer was washed successively with water and with a saturated aqueous solution of sodium chloride, dried over anhydrous sodium sulphate and concentrated by evaporation under reduced pressure. When a small amount of water was added to the residual syrup, it solidified and was separated by filtration. This product (143 mg) was then purified by silica gel column chromatography (eluent: chloroform/methanol 10:1 by volume) to afford 55 mg. of the desired compound as a white powdery solid, melting at 199°-200° C.; [α]24 -81.6° (C=0.5, methanol).

後処理

  1. additionthere were then added 50 mg
  2. additionThe resulting solution was added to a cooled solution
  3. customprepared from 5 ml
  4. stirringThe mixture was stirred overnight at room temperature
  5. customThe dicyclohexylurea precipitated
  6. customwas removed by filtration
  7. concentrationthe filtrate was concentrated by evaporation under reduced pressure
  8. additionTo the residue was added a 5% w/v aqueous solution of sodium bicarbonate
  9. customthe oily substance thus formed
  10. extractionwas extracted with ethyl acetate
  11. washThe organic layer was washed successively with water and with a saturated aqueous solution of sodium chloride
  12. dry with materialdried over anhydrous sodium sulphate
  13. concentrationconcentrated by evaporation under reduced pressure
  14. additionWhen a small amount of water was added to the residual syrup, it
  15. customwas separated by filtration
  16. customThis product (143 mg) was then purified by silica gel column chromatography (eluent: chloroform/methanol 10:1 by volume)
  17. customto afford 55 mg

出典と根拠

ORDレコード
ord-fbd3c44111994d06bf127e1c8baa3ccd
出典データセット
uspto-grants-1985_10
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US04548926

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート